Lymphatic System Cancer
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RANK (Activator of NFKB,CD 265,CD265,CD265 Antigen,EOF,FEO,LOH18CR1,Loss of Heterozygosity 18 Chromosomal Region 1,mRANK,NFKB Activator,ODFR,OFE,OPTB7,Osteoclast Differentiation Factor Receptor,OSTS,PDB 2,PDB2,Receptor A | Login | RANK (Activator of NFKB,CD 265,CD265,CD265 Antigen,EOF,FEO,LOH18CR1,Loss of Heterozygosity 18 Chromosomal Region 1,mRANK,NFKB Activator,ODFR,OFE,OPTB7,Osteoclast Differentiation Factor Receptor,OSTS,PDB 2,PDB2,Receptor A | ||||||||||||||||
|
||||||||||||||||||
| BCL10 (Bcl10, B-cell Lymphoma/Leukemia 10) | Login | BCL10 (Bcl10, B-cell Lymphoma/Leukemia 10) | ||||||||||||||||
|
||||||||||||||||||
| BCL10 Antibody [4F8E8H8] | Login | BCL10 Antibody [4F8E8H8] | ||||||||||||||||
|
||||||||||||||||||
| IFNgamma Antibody [3F1E3] | Login | IFNgamma Antibody [3F1E3] | ||||||||||||||||
|
||||||||||||||||||
| KSHVK8a Antibody [8C12G10G1] | Login | KSHVK8a Antibody [8C12G10G1] | ||||||||||||||||
|
||||||||||||||||||
| NPM1 Antibody [7H10B9] | Login | NPM1 Antibody [7H10B9] | ||||||||||||||||
|
||||||||||||||||||
| Multi Cytokeratin 4/5/6/8/10/13/18 Antibody [C11] | Login | Multi Cytokeratin 4/5/6/8/10/13/18 Antibody [C11] | ||||||||||||||||
|
||||||||||||||||||
| KSHVORF45 Antibody [2D4A5] | Login | KSHVORF45 Antibody [2D4A5] | ||||||||||||||||
|
||||||||||||||||||
| KSHVORF62 Antibody [5B7B6] | Login | KSHVORF62 Antibody [5B7B6] | ||||||||||||||||
|
||||||||||||||||||
| Multi-Cytokeratin Antibody [SPM583] | Login | Multi-Cytokeratin Antibody [SPM583] | ||||||||||||||||
|
||||||||||||||||||
| Bcl-10 Antibody | Login | Bcl-10 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Bcl-10 Antibody | Login | Bcl-10 Antibody | ||||||||||||||||
|
||||||||||||||||||
| BCL-10 Peptide | Login | BCL-10 Peptide | ||||||||||||||||
|
||||||||||||||||||
| HMGCL Antibody | Login | HMGCL Antibody | ||||||||||||||||
|
||||||||||||||||||
| ADAM10 Antibody | Login | ADAM10 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ADAM10 Antibody | Login | ADAM10 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CXCL13 Antibody | Login | CXCL13 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ODF1 Antibody | Login | ODF1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human Tumor Tissue Blot IV | Login | Human Tumor Tissue Blot IV | ||||||||||||||||
|
||||||||||||||||||
| BCL10 Antibody, KO Validated | Login | BCL10 Antibody, KO Validated | ||||||||||||||||
|
||||||||||||||||||
| Lymphoma Tumor Lysate | Login | Lymphoma Tumor Lysate | ||||||||||||||||
|
||||||||||||||||||
| non-Hodgkin's Lymphoma Tumor Lysate | Login | non-Hodgkin's Lymphoma Tumor Lysate | ||||||||||||||||
|
||||||||||||||||||
| BCL2 (B Cell CLL/lymphoma 2, BCL2, Bcl-2, Apoptosis Regulator Bcl-2) | Login | BCL2 (B Cell CLL/lymphoma 2, BCL2, Bcl-2, Apoptosis Regulator Bcl-2) | ||||||||||||||||
|
||||||||||||||||||
| CBL (E3 Ubiquitin-protein Ligase CBL, Casitas B-lineage Lymphoma Proto-oncogene, Proto-oncogene c-Cbl, RING Finger Protein 55, Signal Transduction Protein CBL, CBL2, RNF55) | Login | CBL (E3 Ubiquitin-protein Ligase CBL, Casitas B-lineage Lymphoma Proto-oncogene, Proto-oncogene c-Cbl, RING Finger Protein 55, Signal Transduction Protein CBL, CBL2, RNF55) | ||||||||||||||||
|
||||||||||||||||||
| TAOK3 (DPK,JIK,KDS,MAP3K18,Serine/Threonine-protein Kinase TAO3,Cutaneous T-cell Lymphoma-associated Antigen HD-CL-09,Dendritic Cell-derived Protein Kinase,JNK/SAPK-inhibitory Kinase,Jun Kinase-inhibitory Kinase,Kinase f | Login | TAOK3 (DPK,JIK,KDS,MAP3K18,Serine/Threonine-protein Kinase TAO3,Cutaneous T-cell Lymphoma-associated Antigen HD-CL-09,Dendritic Cell-derived Protein Kinase,JNK/SAPK-inhibitory Kinase,Jun Kinase-inhibitory Kinase,Kinase f | ||||||||||||||||
|
||||||||||||||||||


